Nanmo Biotech announced that from July 15, 2026 to September 23, 2026, Wang Jinjin reduced his holdings by a total of 2,500 shares through centralized bidding transactions, accounting for 0.0032% of the company's total share capital. The plan to reduce holdings has been completed. After the holdings were reduced, Wang Jinjin held 7,500 shares of the company, accounting for 0.0096% of the total share capital.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.